|
⚲
|
| Keyboard |
| Robert van Nostrand | |
|---|---|
| Firm | |
| Address | 361 Newbury Street, 5th Floor Boston, MA 02115 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Likeminds Inc/DE | 021-402731 | Director | 1.1 M of 1.1 M |
||
| Sellas Life Sciences Group Inc | 021-374517 | Director | 9.2 M of 9.2 M |
||
| Likeminds Inc/DE | 021-321800 | Director | 5.2 M of 5.2 M |
||
| Yield10 Bioscience Inc | 021-290745 | Director | 2.3 M of 2.3 M |
||
| Enumeral Biomedical Holdings Inc | 021-287510 | Director | 0.7 M of 3.6 M |
||
| Enumeral Biomedical Holdings Inc | 021-276313 | Director | 3.4 M of 10.8 M |
||
| Enumeral Biomedical Holdings Inc | 021-268167 | Director | 3.0 M of 3.5 M |
||
| Metabolix Inc | 021-224265 | Director | 25.0 M of 25.0 M |
||
| Achillion Pharmaceuticals Inc | 021-146800 | Director | 50.1 M of 50.1 M |
||
| Aureon Laboratories Inc | 021-78598 | Executive Officer | 7.0 M of 18.0 M |
||